With just 12 days left in the year, it appears there won't be a decision from the US Food and Drug Administration (FDA) on whether AquaBounty Technologies’ genetically modified salmon will be approved for sale in the United States, but it’s not going to dampen the spirits of the company’s CEO Ron Stotish.
Stotish told IntraFish on Wednesday he remains focused on the company’s positive achievements, such as the recent approval to produce its sterile, all-female eggs in Canada, despite critics and activists.
“We’re
